OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.

Registration to our newsletter is FREE, Join today by entering your email below!

Tag Archives: hemispherx biopharma

With New Information Indicating Effectiveness of Ampligen is Hemispherx Biopharma Any Closer to FDA Approval

Shareholders in Hemispherx Biopharma, Inc. (AMEX: HEB) have been waiting a considerable period of time for the specialty pharmaceutical company to deliver positive news regarding their Phase III trial involving the experimental therapeutic Ampligen. On Monday that news may have … Continue reading

Posted in AMEX, Articles | Tagged , , , , , , , , , , , | Leave a comment

Hemispherx Biopharma’s Lengthy Struggle to Bring Chronic Fatigue Syndrome Drug Ampligen to Market Leaving Investors Weary, Where is HEB Heading Next?

It has been nearly a year since Hemispherx Biopharma, Inc. (NYSE AMEX: HEB) received the news that Ampligen, the Chronic Fatigue Syndrome (CFS) drug they have been working on for more than three decades, was not being approved by the … Continue reading

Posted in AMEX, Articles | Tagged , , , , , , , , , | Leave a comment